Bionomics Ltd ADR Valuation
| BNOXDelisted Stock | USD 4.88 0.07 1.41% |
At this time, the firm appears to be overvalued. Bionomics ADR shows a prevailing Real Value of $4.1 per share. The current price of the firm is $4.88. Our model approximates the value of Bionomics ADR from analyzing the firm fundamentals such as Return On Equity of -0.78, shares outstanding of 1.63 M, and Operating Margin of 89.10 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Bionomics' price fluctuation is extremely dangerous at this time. Calculation of the real value of Bionomics ADR is based on 3 months time horizon. Increasing Bionomics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Bionomics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bionomics Stock. However, Bionomics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.88 | Real 4.1 | Hype 4.88 | Naive 4.29 |
The intrinsic value of Bionomics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Bionomics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Bionomics Ltd ADR helps investors to forecast how Bionomics stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bionomics more accurately as focusing exclusively on Bionomics' fundamentals will not take into account other important factors: Bionomics Total Value Analysis
Bionomics Ltd ADR is currently estimated to have valuation of 14.16 B with market capitalization of 4.95 M, debt of 272.74 K, and cash on hands of 33.56 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Bionomics fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
14.16 B | 4.95 M | 272.74 K | 33.56 M |
Bionomics Investor Information
About 34.0% of the company shares are held by company insiders. The company recorded a loss per share of 14.32. Bionomics ADR had not issued any dividends in recent years. The entity had 1:12 split on the 24th of December 2024. Based on the key indicators related to Bionomics' liquidity, profitability, solvency, and operating efficiency, Bionomics Ltd ADR is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.Bionomics Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Bionomics has an asset utilization ratio of 0.0723 percent. This suggests that the Company is making $7.23E-4 for each dollar of assets. An increasing asset utilization means that Bionomics Ltd ADR is more efficient with each dollar of assets it utilizes for everyday operations.Bionomics Ownership Allocation
Bionomics Ltd ADR retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.Bionomics Profitability Analysis
The company reported the previous year's revenue of 20 K. Net Loss for the year was (15.49 M) with loss before overhead, payroll, taxes, and interest of (18.96 M).About Bionomics Valuation
Our relative valuation model uses a comparative analysis of Bionomics. We calculate exposure to Bionomics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Bionomics's related companies.Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. Bionomics Limited was incorporated in 1996 and is based in Eastwood, Australia. Bionomics is traded on NASDAQ Exchange in the United States.
Bionomics Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 10 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in Bionomics Stock
If you are still planning to invest in Bionomics ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bionomics' history and understand the potential risks before investing.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |